verapamil has been researched along with Parasitemia in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Parasitemia: The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ellagic acid is a polyphenol found in various plant products." | 1.35 | In vitro and in vivo properties of ellagic acid in malaria treatment. ( Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B, 2009) |
| "These findings, consistent with a dilated cardiomyopathy, were ameliorated in the early but not in the late treatment group, demonstrating that late treatment with verapamil is ineffective in reversing the development of chagasic cardiomyopathy in chronically infected mice." | 1.32 | Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. ( Chandra, M; De Souza, AP; Factor, SM; Huang, H; Jelicks, LA; Morris, SA; Shirani, J; Shtutin, V; Tanowitz, HB; Weiss, LM; Wittner, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soh, PN | 1 |
| Witkowski, B | 1 |
| Olagnier, D | 1 |
| Nicolau, ML | 1 |
| Garcia-Alvarez, MC | 1 |
| Berry, A | 1 |
| Benoit-Vical, F | 1 |
| De Souza, AP | 1 |
| Tanowitz, HB | 1 |
| Chandra, M | 1 |
| Shtutin, V | 1 |
| Weiss, LM | 1 |
| Morris, SA | 1 |
| Factor, SM | 1 |
| Huang, H | 1 |
| Wittner, M | 1 |
| Shirani, J | 1 |
| Jelicks, LA | 1 |
| Tamez, PA | 1 |
| Lantvit, D | 1 |
| Lim, E | 1 |
| Pezzuto, JM | 1 |
| Hess, FI | 1 |
| Kilian, A | 1 |
| Söllner, W | 1 |
| Nothdurft, HD | 1 |
| Pröll, S | 1 |
| Löscher, T | 1 |
4 other studies available for verapamil and Parasitemia
| Article | Year |
|---|---|
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationshi | 2009 |
Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection.
Topics: Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Chagas Cardiomyopathy; Chagas Disease; Dis | 2004 |
Chemosensitizing action of cepharanthine against drug-resistant human malaria, Plasmodium falciparum.
Topics: Alkaloids; Animals; Benzylisoquinolines; Chloroquine; Disease Models, Animal; Dose-Response Relation | 2005 |
Plasmodium falciparum and Plasmodium berghei: effect of magnesium on the development of parasitemia.
Topics: Analysis of Variance; Animals; Calcium; Chloroquine; Culture Media; Dose-Response Relationship, Drug | 1995 |